Severe 5-Fluorouracil-Associated Gastrointestinal Toxicity Unexplained by Dihydropyrimidine Dehydrogenase Deficiency and Renal Impairment: Should We Be Investigating Other Elimination Pathways to Assess the Risk of 5-Fluorouracil Toxicity?
- 27 September 2021
- journal article
- letter
- Published by Springer Nature in European Journal of Drug Metabolism and Pharmacokinetics
- Vol. 46 (6) , 817-820
Abstract
No abstract availableFunding Information
- Genesis Oncology Trust, New Zealand (GOT 14S1-RPG)
- Breast Cancer Foundation New Zealand (F1603)
- The School of Medicine Foundation, University of Auckland, New Zealand
This publication has 24 references indexed in Scilit:
- Role of ABC Transporters in Fluoropyrimidine-Based Chemotherapy Response2015
- Gender-specific elimination of continuous-infusional 5-fluorouracil in patients with gastrointestinal malignancies: results from a prospective population pharmacokinetic studyCancer Chemotherapy and Pharmacology, 2012
- Routine Dihydropyrimidine Dehydrogenase Testing for Anticipating 5-Fluorouracil–Related Severe Toxicities: Hype or Hope?Clinical Colorectal Cancer, 2010
- Xeloda® in Adjuvant Colon Cancer Therapy (X-ACT) Trial: Overview of Efficacy, Safety, and Cost-EffectivenessClinical Colorectal Cancer, 2006
- Pharmacokinetic and demographic markers of 5-fluorouracil toxicity in 181 patients on adjuvant therapy for colorectal cancerAnnals of Oncology, 2006
- Differences in toxicity between men and women treated with 5‐fluorouracil therapy for colorectal carcinomaCancer, 2005
- Severe 5-fluorouracil toxicity associated with a marked alteration of pharmacokinetics of 5-fluorouracil and its catabolite 5-fluoro-5,6-dihydrouracil: a case reportEuropean Journal of Clinical Pharmacology, 2002
- Clinical Pharmacology of 5-FluorouracilClinical Pharmacokinetics, 1989
- Metabolism of 5-fluorouracil to an N-cholyl-2-fluoro-beta-alanine conjugate: previously unrecognized role for bile acids in drug conjugation.Proceedings of the National Academy of Sciences, 1987
- Measurement of the renal clearance of drugs.British Journal of Clinical Pharmacology, 1981